ADVM logo

Adverum Biotechnologies (ADVM) Revenue

Annual Revenue

$3.60 M
0.00%

31 December 2023

ADVM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Revenue

$1.00 M
0.00%

30 September 2024

ADVM Quarterly Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Revenue

$1.00 M
0.00%

30 September 2024

ADVM TTM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADVM Revenue Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years+123.3%+300.0%+212.5%

ADVM Revenue High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-52.0%at low-72.2%at low-72.2%at low
5 y5 years-52.0%+1340.0%-86.7%+300.0%-86.7%+212.5%
alltimeall time-52.0%+1340.0%-86.7%+3233.3%-86.7%+3233.3%

Adverum Biotechnologies Revenue History

DateAnnualQuarterlyTTM
Sept 2024
-
$1.00 M(-72.2%)
$1.00 M(-72.2%)
Dec 2023
$3.60 M(-52.0%)
-
-
Mar 2023
-
$3.60 M(-52.0%)
$3.60 M(-52.0%)
Dec 2021
$7.50 M(+2900.0%)
-
-
Mar 2021
-
$7.50 M(+2900.0%)
$7.50 M(+2243.8%)
Dec 2019
$250.00 K(-84.5%)
-
-
Sept 2019
-
$250.00 K(+257.1%)
$320.00 K(-80.1%)
Dec 2018
$1.61 M(-12.8%)
$70.00 K(-91.6%)
$1.61 M(-19.5%)
Sept 2018
-
$833.00 K(+69.0%)
$2.00 M(+22.7%)
June 2018
-
$493.00 K(+128.2%)
$1.63 M(+1.9%)
Mar 2018
-
$216.00 K(-53.1%)
$1.60 M(-13.3%)
Dec 2017
$1.85 M
$461.00 K(-0.4%)
$1.85 M(-1.4%)
Sept 2017
-
$463.00 K(0.0%)
$1.88 M(+3.8%)
DateAnnualQuarterlyTTM
June 2017
-
$463.00 K(+0.2%)
$1.81 M(+9.4%)
Mar 2017
-
$462.00 K(-5.3%)
$1.65 M(+13.5%)
Dec 2016
$1.46 M(-37.3%)
$488.00 K(+23.5%)
$1.46 M(-24.5%)
Sept 2016
-
$395.00 K(+28.7%)
$1.93 M(-22.5%)
June 2016
-
$307.00 K(+15.8%)
$2.48 M(+4.4%)
Mar 2016
-
$265.00 K(-72.4%)
$2.38 M(+2.7%)
Dec 2015
$2.32 M(+305.4%)
$960.00 K(+0.7%)
$2.32 M(+48.5%)
Sept 2015
-
$953.00 K(+369.5%)
$1.56 M(+92.1%)
June 2015
-
$203.00 K(0.0%)
$813.00 K(+9.1%)
Mar 2015
-
$203.00 K(0.0%)
$745.00 K(+30.2%)
Dec 2014
$572.00 K
$203.00 K(-0.5%)
$572.00 K(+55.0%)
Sept 2014
-
$204.00 K(+51.1%)
$369.00 K(+123.6%)
June 2014
-
$135.00 K(+350.0%)
$165.00 K(+450.0%)
Mar 2014
-
$30.00 K
$30.00 K

FAQ

  • What is Adverum Biotechnologies annual revenue?
  • What is the all time high annual revenue for Adverum Biotechnologies?
  • What is Adverum Biotechnologies quarterly revenue?
  • What is the all time high quarterly revenue for Adverum Biotechnologies?
  • What is Adverum Biotechnologies TTM revenue?
  • What is the all time high TTM revenue for Adverum Biotechnologies?

What is Adverum Biotechnologies annual revenue?

The current annual revenue of ADVM is $3.60 M

What is the all time high annual revenue for Adverum Biotechnologies?

Adverum Biotechnologies all-time high annual revenue is $7.50 M

What is Adverum Biotechnologies quarterly revenue?

The current quarterly revenue of ADVM is $1.00 M

What is the all time high quarterly revenue for Adverum Biotechnologies?

Adverum Biotechnologies all-time high quarterly revenue is $7.50 M

What is Adverum Biotechnologies TTM revenue?

The current TTM revenue of ADVM is $1.00 M

What is the all time high TTM revenue for Adverum Biotechnologies?

Adverum Biotechnologies all-time high TTM revenue is $7.50 M